NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE274958 Query DataSets for GSE274958
Status Public on Jan 28, 2025
Title Effects of MRSA and FTY720 S-phosphonate on H3K9 acetylation in human lung endothelial cells
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Methicillin-resistant Staph. Aureus (MRSA) is a common cause of severe pneumonia and sepsis that can lead to Acute Respiratory Distress Syndrome (ARDS). MRSA causes lung endothelial cell (EC) dysfunction, a critical step in the pathogenesis and progression of lung injury. Our previous studies have demonstrated that FTY720 S-phosphonate (Tysiponate, Tys), an analog of sphingosine-1-phosphate, ameliorates MRSA-induced lung EC activation and barrier disruption (PMID: 35015568). To advance our mechanistic understanding of MRSA and Tys effects on lung EC, we investigated associated epigenetic changes. Specifically, we studied histone lysine acetylation, which is a central epigenetic alteration that has been linked to gene transcription and functional regulation of endothelial responses to inflammatory stimuli. We therefore determined the effects of MRSA exposure in the presence or absence of Tys on lung EC acetylation at the 9th lysine residue of the histone H3 protein (H3K9ac), which is an important chromatin modification associated with active promoters and gene activation. ChIP-seq analysis was employed to perform an unbiased genome-wide profiling of H3K9ac epigenetic patterns in human lung EC. This analysis identified multiple genes that are differentially targeted by acetylation when EC are exposed to MRSA±Tys.
 
Overall design Chromatin immunoprecipitation sequencing (Chip-Seq) for histone modification H3K9 acetylation in human pulmonary artery endothelial cells treated with heat-killed methicillin resistant Staph Aureus (HK-MRSA), Tysiponate (FTY720 S-phosphonate; S1P analogue),or HK-MRSA +Tys for 30 min. Cells treated only with vehicle were used as control.
 
Contributor(s) Ha AW, Meliton LN, Wang L, Maienschein-Cline M, Letsiou E, Dudek SM
Citation(s) 39588951
Submission date Aug 15, 2024
Last update date Jan 29, 2025
Contact name Mark Maienschein-Cline
E-mail(s) mmaiensc@uic.edu
Organization name University of Illinois at Chicago
Department Research Resources Center
Lab Center for Research Informatics
Street address 1819 W Polk Ave, Rm 336 M/C 789
City Chicago
State/province IL
ZIP/Postal code 60612
Country USA
 
Platforms (1)
GPL20301 Illumina HiSeq 4000 (Homo sapiens)
Samples (5)
GSM8462825 input
GSM8462826 control_no-treat
GSM8462827 MRSA_no-treat
Relations
BioProject PRJNA1148644

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE274958_RAW.tar 3.5 Mb (http)(custom) TAR (of BED)
GSE274958_peak_counts.txt.gz 597.3 Kb (ftp)(http) TXT
GSE274958_peak_merged.bed.gz 691.5 Kb (ftp)(http) BED
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap